Appeals Court Dismisses Illumina Patent Lawsuit Against Affymetrix | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The US Court of Appeals for the Federal Circuit has affirmed the dismissal of lawsuits filed by Illumina against Affymetrix alleging patent infringement, Affy announced today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.

In Science this week: new chromatin imaging approach, and more.